help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrine Reviews, doi:10.1210/edrv-14-4-401
Endocrine Reviews 14 (4): 401-423
Copyright © 1993 by The Endocrine Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROTI, E.
Right arrow Articles by BRAVERMAN, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROTI, E.
Right arrow Articles by BRAVERMAN, L. E.

The Use and Misuse of Thyroid Hormone*

ELIO ROTI, ROBERTA MINELLI{dagger}, ELIANA GARDINI{dagger} and LEWIS E. BRAVERMAN

Centro per lo Studio, Prevenzione, Diagnosi e Cura della Tireopatie, Cattedra di Endocrinologia, Universita di Parma Parma, Italy
The Division of Endocrinology and Metabolism, University of Massachusetts Medical School Worcester, Massachusetts 01655

Correspondence: Address requests for reprints to: Lewis E. Braverman, M.D., Division of Endocrinology and Metabolism, University of Massachusetts, 55 Lake Avenue North, Worcester, Massachusetts 01655.

Abstract

I. Introduction: THYROID hormones are frequently prescribed for appropriate and, at times, inappropriate conditions. It has been estimated that 1.2% of the total population in Sweden receives synthetic levothyroxine (L-T4) (1), and 18 million prescriptions for thyroid hormone preparations are filled annually in the United States, corresponding to more than 1% of all medical prescriptions (2). Therefore, it is important to review the various thyroid hormone preparations (Table 1), the therapeutic indications (Table 2), the misuse of thyroid hormone (Table 3), controversial uses of thyroid hormone (Table 4), the thyroid function tests to evaluate the correct treatment dose, and the possible side effects of treatment.

Thyroid Hormone Preparations: A. Thyroid extract

Since 1891, when Murray reported the beneficial effects of sheep thyroid extract given im to a patient with myxedema (3), desiccated thyroid has been used in the treatment of patients with thyroid disease. Thyroid extract is obtained from animal thyroid glands, primarily cattle, and contains T4 and T3 in variable ratios, depending upon the preparation process and the iodine content in the diet of the animals from which the thyroids have been obtained, resulting in variable quantities of T4 and T3 in the extract.

Footnotes

* This work was supported in part by Grants 89.04244.04, 90.01540.CT04, and 91.00316.CT04 from Consiglio Nazionale delle Ricerche (Rome, Italy); Grant "Patologia della Tiroide: Indagine dei Fattori Etiopatogenetici" of Ministero Pubblica Istruzione 40% (Rome, Italy); Grant Ricerca Finalizzata Regione Emilia Romagna 1988–1990; and NIH Grant DK-18919.

{dagger} Recipients of a fellowship from Associazione Volontaria Promozione Ricerca Tumori (A.VO.PRO.RI.T.), Parma, Italy.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
W. Russell, R. F. Harrison, N. Smith, K. Darzy, S. Shalet, A. P. Weetman, and R. J. Ross
Free Triiodothyronine Has a Distinct Circadian Rhythm That Is Delayed but Parallels Thyrotropin Levels
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2300 - 2306.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. P. Walsh, L. C. Ward, V. Burke, C. I. Bhagat, L. Shiels, D. Henley, M. J. Gillett, R. Gilbert, M. Tanner, and B. G. A. Stuckey
Small Changes in Thyroxine Dosage Do Not Produce Measurable Changes in Hypothyroid Symptoms, Well-Being, or Quality of Life: Results of a Double-Blind, Randomized Clinical Trial
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2624 - 2630.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M. G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, et al.
Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 124 - 127.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. S. Cooper
Combined T4 and T3 Therapy--Back to the Drawing Board
JAMA, December 10, 2003; 290(22): 3002 - 3004.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. P. Walsh, L. Shiels, E. M. Lim, C. I. Bhagat, L. C. Ward, B. G. A. Stuckey, S. S. Dhaliwal, G. T. Chew, M. C. Bhagat, and A. J. Cussons
Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4543 - 4550.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Ferretti, L. Persani, M.-L. Jaffrain-Rea, S. Giambona, G. Tamburrano, and P. Beck-Peccoz
Evaluation of the Adequacy of Levothyroxine Replacement Therapy in Patients with Central Hypothyroidism
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 924 - 929.
[Abstract] [Full Text]


Home page
JAMAHome page
P. A. Singer, D. S. Cooper, E. G. Levy, P. W. Ladenson, L. E. Braverman, G. Daniels, F. S. Greenspan, I. R. McDougall, and T. F. Nikolai
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
JAMA, March 8, 1995; 273(10): 808 - 812.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society